CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Purdue Pharma Products LP v. Par Pharmaceuticals Inc.

1:07-cv-00255

Overview

Case Number 1:07-cv-00255
Filing Date 2007-05-09
Status Terminated
Termination Date 2009-08-14
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Par Pharmaceutical Companies Inc. Operating Company

Represented By

5 Attorneys Listed

Frederick L. Cottrell , III

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Steven J. Fineman

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Anna Brandl

Email: abrandl@kslaw.com

Stephen M. Ferguson

Benesch Friedlander Coplan & Aronoff

Tel: +1 (302) 442-7010

Benesch Friedlander Coplan & Aronoff, 222 Delaware Ave, Ste. 801

Par Pharmaceuticals Inc. Operating Company

Represented By

6 Attorneys Listed

Frederick L. Cottrell , III

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Robert E. Colletti

Email: rcolletti@flhlaw.com

Edgar H. Haug

Email: ehaug@flhlaw.com

Steven J. Fineman

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Nicole W. Stafford

Email: nstafford@wsgr.com

Stephen M. Ferguson

Benesch Friedlander Coplan & Aronoff

Tel: +1 (302) 442-7010

Benesch Friedlander Coplan & Aronoff, 222 Delaware Ave, Ste. 801

Plaintiff

Ortho-McNeil Inc. Operating Company

Represented By

4 Attorneys Listed

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Richard D. Kirk

Bayard, P.A.

Tel: +1 (302) 429-4208
Fax: +1 (302) 658-6395

Bayard, P.A., 222 Delaware Avenue, Suite 900

Rodger Dallery Smith , II

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9205

1201 North Market Street, P.O. Box 1347

Mary W. Bourke

Womble Carlyle Sandridge Rice

Tel: +1 (302) 252-4320

Womble Carlyle Sandridge Rice, 222 Delaware Avenue

Biovail Laboratories International SRL Operating Company

Represented By

5 Attorneys Listed

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Richard D. Kirk

Bayard, P.A.

Tel: +1 (302) 429-4208
Fax: +1 (302) 658-6395

Bayard, P.A., 222 Delaware Avenue, Suite 900

Rodger Dallery Smith , II

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9205

1201 North Market Street, P.O. Box 1347

Mary W. Bourke

Womble Carlyle Sandridge Rice

Tel: +1 (302) 252-4320

Womble Carlyle Sandridge Rice, 222 Delaware Avenue

Purdue Pharma Products LP NPE (University / Research)

Represented By

4 Attorneys Listed

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Richard D. Kirk

Bayard, P.A.

Tel: +1 (302) 429-4208
Fax: +1 (302) 658-6395

Bayard, P.A., 222 Delaware Avenue, Suite 900

Rodger Dallery Smith , II

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9205

1201 North Market Street, P.O. Box 1347

Mary W. Bourke

Womble Carlyle Sandridge Rice

Tel: +1 (302) 252-4320

Womble Carlyle Sandridge Rice, 222 Delaware Avenue

Napp Pharmaceutical Group Ltd. Operating Company

Represented By

4 Attorneys Listed

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Richard D. Kirk

Bayard, P.A.

Tel: +1 (302) 429-4208
Fax: +1 (302) 658-6395

Bayard, P.A., 222 Delaware Avenue, Suite 900

Rodger Dallery Smith , II

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9205

1201 North Market Street, P.O. Box 1347

Mary W. Bourke

Womble Carlyle Sandridge Rice

Tel: +1 (302) 252-4320

Womble Carlyle Sandridge Rice, 222 Delaware Avenue

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 11 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (11): 🇩🇪 Germany GB 🇺🇸 US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6254887
Controlled release tramadol
Filed: 1996-07-10
Issued: 2001-07-03
Expired (Term Ended)
Expires: 2016-07-10
US7074430
Controlled release tramadol tramadol formulation
Filed: 2001-03-06
Issued: 2006-07-11
Expired (Term Ended)
Expires: 2021-03-06

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

90

Dispositive

0

Granted

4

Denied

2

Pending / Review

84

Motions by Category

Procedural / Extension Motion 14 Motion to Compel Discovery 25 Claim Construction / Markman Filing 46 Motion to Strike / Sanctions 5

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to File Motion for Attorneys' Fees to 40 days after entry of judgment if no appeal or 10 days after entry of mandate if appealed - fi...
Entry #352 • 2009-08-28 Document →
Claim Construction / Markman Filing Pending / Under Review
REDACTED VERSION of 297 Reply Brief, in Support of Their Motion for Leave to Supplement the Expert Reports of Dr. Martyn C. Davies and Dr. Warren A. Katz to Add...
Entry #302 • 2008-12-18 Document →
Claim Construction / Markman Filing Pending / Under Review
REDACTED VERSION of 298 Declaration, of Sasha G. Rao in Support of Plaintiffs' Motion for Leave to Supplement the Expert Reports of Dr. Martyn C. Davies and Dr....
Entry #303 • 2008-12-18 Document →
Procedural / Extension Motion Pending / Under Review
Order Setting Teleconference: Telephone Conference set for 12/18/2008 09:30 AM before Judge Kent A. Jordan re motion for leave to suppl. expert reports 282, and...
Entry #301 • 2008-12-15 Document →
Procedural / Extension Motion Pending / Under Review
REDACTED VERSION of 292 Answering Brief in Opposition, to Plaintiffs' Motion for Leave to Supplement the Expert Reports of Dr. Martyn C. Davies and Dr. Warren A...
Entry #299 • 2008-12-12 Document →
Procedural / Extension Motion Pending / Under Review
REDACTED VERSION of 293 Declaration of Steven J. Fineman in Support of Par's Opposition to Plaintiffs' Motion for Leave to Supplement the Expert Reports of Dr. ...
Entry #300 • 2008-12-12 Document →

Docket Entries

(385 total)
Pleading / Complaint

COMPLAINT filed against Par Pharmaceuticals Inc., Par Pharmaceutical Companies Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 147503.) - filed by Purdue Pharma Products LP, Napp Pharmaceutical Group Ltd., Biovail Laboratories International SRL, Ortho-McNeil Inc. (Attachments: # 1 Civil Cover Sheet # 2 Acknowledgement of Consent Form)(ead) (Entered: 05/10/2007)

Entry #1 • 2007-05-09
1

Notice of Availability of a U.S. Magistrate Judge to Exercise Jurisdiction (ead) (Entered: 05/10/2007)

Entry #2 • 2007-05-09
1

Disclosure Statement pursuant to Rule 7.1 filed by Purdue Pharma Products LP, Napp Pharmaceutical Group Ltd. identifying Napp Pharmaceuticals Holdings Limited as Corporate Parent for Napp Pharmaceutical Group Ltd. (ead) (Entered: 05/10/2007)

Entry #3 • 2007-05-09
1

Disclosure Statement pursuant to Rule 7.1 filed by Ortho-McNeil Inc. identifying Johnson and Johnson as Corporate Parent. (ead) (Entered: 05/10/2007)

Entry #4 • 2007-05-09
1

Disclosure Statement pursuant to Rule 7.1 filed by Biovail Laboratories International SRL. (ead) (Entered: 05/10/2007)

Entry #5 • 2007-05-09
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc